Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference
Outset Medical (NASDAQ: OM), a medical technology company focused on revolutionizing dialysis through innovative technology, has announced its participation in the upcoming 23rd Annual Morgan Stanley Global Healthcare Conference. The company's management will deliver their presentation on September 10, 2025, at 7:00 AM ET.
Investors and interested parties can access both the live presentation and archived webcast through the investor relations section of Outset Medical's website at investors.outsetmedical.com.
Outset Medical (NASDAQ: OM), azienda di tecnologia medicale dedicata a rivoluzionare la dialisi tramite soluzioni innovative, ha annunciato la sua partecipazione alla 23ª Annuale Morgan Stanley Global Healthcare Conference. Il management terrà la presentazione il 10 settembre 2025 alle 07:00 ET.
Investitori e interessati possono seguire la presentazione dal vivo e l'archivio webcast nella sezione investor relations del sito di Outset Medical all'indirizzo investors.outsetmedical.com.
Outset Medical (NASDAQ: OM), una compañía de tecnología médica centrada en revolucionar la diálisis mediante tecnología innovadora, ha anunciado su participación en la 23ª Conferencia Anual Morgan Stanley Global Healthcare. La dirección de la empresa realizará su presentación el 10 de septiembre de 2025 a las 07:00 ET.
Los inversores e interesados pueden acceder tanto a la presentación en directo como al webcast archivado en la sección de relaciones con inversores del sitio web de Outset Medical en investors.outsetmedical.com.
Outset Medical (NASDAQ: OM), 혁신적인 기술로 투석 분야를 혁신하는 데 주력하는 의료기술 기업이 제23회 연례 모건스탠리 글로벌 헬스케어 콘퍼런스에 참가한다고 발표했습니다. 회사 경영진의 발표는 2025년 9월 10일 오전 7:00 ET에 진행됩니다.
투자자 및 관심 있는 분들은 Outset Medical 웹사이트의 투자자 정보 섹션 investors.outsetmedical.com에서 라이브 프레젠테이션과 아카이브 웹캐스트를 모두 시청할 수 있습니다.
Outset Medical (NASDAQ: OM), une entreprise de technologies médicales visant à révolutionner la dialyse grâce à des technologies innovantes, a annoncé sa participation à la 23e conférence annuelle Morgan Stanley Global Healthcare. La direction donnera sa présentation le 10 septembre 2025 à 07h00 ET.
Les investisseurs et toute personne intéressée peuvent accéder à la présentation en direct ainsi qu'au webcast archivé via la rubrique relations investisseurs du site d'Outset Medical à l'adresse investors.outsetmedical.com.
Outset Medical (NASDAQ: OM), ein Medizintechnologieunternehmen, das die Dialyse durch innovative Technologie revolutionieren möchte, hat seine Teilnahme an der 23. jährlichen Morgan Stanley Global Healthcare Conference angekündigt. Die Unternehmensleitung wird ihre Präsentation am 10. September 2025 um 07:00 Uhr ET halten.
Investoren und Interessierte können die Live-Präsentation sowie das Archiv-Webcast im Investor-Relations-Bereich von Outset Medical unter investors.outsetmedical.com abrufen.
- None.
- None.
SAN JOSE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the 23rd annual Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 10, 2025, at 7 a.m. Eastern time.
A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company transforming the dialysis experience across the continuum of care with a first-of-its-kind technology. The Tablo® Hemodialysis System, FDA-cleared for use from hospital to home, is trusted by more than 1,000 U.S. healthcare facilities and has enabled millions of treatments delivered by thousands of nurses. Designed to reduce the cost and complexity of dialysis, Tablo combines water purification and on-demand dialysate production into a single, integrated system that connects seamlessly with Electronic Medical Record systems and a proprietary data analytics platform. This enterprise solution empowers providers to develop an in-house dialysis program where they are in control – enabling better operational, clinical, and financial outcomes. Outset is redefining what’s possible in kidney care through innovation, scale, and a relentless commitment to improving the lives of patients and the professionals who care for them. For more information, visit www.outsetmedical.com.
Contact
Jim Mazzola
Investor Relations
jmazzola@outsetmedical.com
FAQ
When is Outset Medical (OM) presenting at the Morgan Stanley Healthcare Conference 2025?
How can I watch Outset Medical's (OM) Morgan Stanley conference presentation?
What does Outset Medical (OM) specialize in?
Where can investors find the replay of Outset Medical's (OM) Morgan Stanley conference presentation?
